Horizon Discovery, Promega Partner on Predictive Human Disease Models | GenomeWeb

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Horizon Discovery today announced a collaboration with Promega to develop next-generation predictive human disease models.

The partnership, it said, centers on delivering "endogenous gene reporting capabilities in the form of Promega's luciferase and HaloTag reporter technologies" combined with Horizon Discovery's homologous recombination-based precision genome editing technology called rAAV Genesis.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PNAS this week: carbapenem resistance in Enterobacteriaceae, selection against educational attainment-linked variants, and more.

Technology Review points out that a new US presidential science advisor hasn't been selected.

Researchers find that blood tests might be able to help determine severity of a concussion, Wired reports.

President-elect Donald Trump considers other candidates for director of the National Institutes of Health, Nature News reports.